Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics
Clinical trial NCT04933383 · COMPLETED
Trial details
- NCT number
- NCT04933383
- Sponsor
- Aquilon Pharmaceuticals S.A.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-23
- Primary completion
- 2022-12-31
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.